TEMPEST THERAPEUTICS INC
TPST · NASDAQ
Updated at 2026-10-14 09:31:18
- Today's High
- $0.74
- Today’s Low
- $0.68
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $0.76
- Previous Close
- $0.74
- Volume
- 163.61K
- Market Cap
- $12.54M
- P/E Ratio
- --
- EPS
- $-4.48
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 2000 SIERRA POINT PARKWAY, BRISBANE, CA, UNITED STATES, 94005
- Country
- US
- Listing Date
- 2012-10-04
- Fiscal Year End
- December
- Shares Outstanding
- 15.98M
- CIK
- 0001544227
- Website
- www.tempesttx.com
Tempest Therapeutics Inc., a clinical-stage oncology company, is dedicated to the development of small molecules that combine targeted and immune-mediated mechanisms with the potential to treat various tumors. The company is headquartered in South San Francisco, California.
Financial Metrics
Revenue
2026-06-30
$0
2026-03-31
$0
2025-12-31
$0
2025-09-30
$0
Operating Expenses
2026-06-30
$5.25M
2026-03-31
$5.53M
2025-12-31
$4.07M
2025-09-30
$3.59M
Net Income
2026-06-30
-$5.24M
2026-03-31
-$27.69M
2025-12-31
-$4.02M
2025-09-30
-$3.51M
Net Profit Margin
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
Earnings Per Share
2026-06-30
$-0.34
2026-03-31
$-0.50
2025-12-31
$-0.62
2025-09-30
$-0.79
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$5.19M
2026-03-31
-$27.63M
2025-12-31
-$3.95M
2025-09-30
-$3.44M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Operating Expenses | $5.25M | $5.53M | $4.07M | $3.59M |
| Net Income | -$5.24M | -$27.69M | -$4.02M | -$3.51M |
| Net Profit Margin | -- | -- | -- | -- |
| Earnings Per Share | $-0.34 | $-0.50 | $-0.62 | $-0.79 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$5.19M | -$27.63M | -$3.95M | -$3.44M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.